All news articles Expertise - Any -Banking & financeCapital markets & listed entitiesCommercial law & consumer lawCompetition and Foreign Direct Investments (“FDI”)Corporate and M&ACriminal enforcement & complianceDawn raidsDigital & data protectionDispute resolution & litigationEmploymentEnergyEstate planning & family businessesHealthcareIntellectual propertyLiability & insuranceLife sciencesMobilityPPP & InfrastructurePensionsPublic & administrative lawReal estateRestructuring & insolvencyState-owned enterprisesTax Date - Any -Last weekLast monthLast 3 monthsLast 6 monthsLast year Search News 18 February 2021 Eubelius appoints a new Partner and three new Counsels Eubelius is particularly pleased to announce the appointment of... News 9 February 2021 Eubelius assists WDP with an ABB of EUR 200 million On 3 February 2021, WDP, the BE-REIT specialising in logistics and semi-industrial real estate in Belgium, the Netherlands, France... News 5 February 2021 Eubelius assists V-Bio Ventures with the launch of its second fund, V-Bio Fund 2, at €78 million V-Bio Ventures is an independent venture capital firm that specialises in building and financing young, innovative life science companies. Keep up to date with legal news We will process your personal data to keep you informed about our services and activities as explained in our privacy policy. News 22 January 2021 Eubelius assists Care Property Invest in connection with a capital increase following the contribution of a residential care centre Eubelius has assisted Care Property Invest (CPI) in connection with a successful capital increase of EUR 42 million following the... News 20 January 2021 Eubelius assists Belden in the acquisition of OTN Systems Group Belden has reached an agreement with the shareholders of OTN Systems NV, the parent company of the OTN Systems Group, for the acquisition of... News 18 December 2020 Eubelius acts as counsel to Soros Economic Development Fund in Series C financing round of Univercells Eubelius assisted the Soros Economic Development Fund (SEDF) in the €70 million Series C financing round of Univercells NV. Load More
